标题
Integrin-Mediated TGFβ Activation Modulates the Tumour Microenvironment
作者
关键词
-
出版物
Cancers
Volume 11, Issue 9, Pages 1221
出版商
MDPI AG
发表日期
2019-08-21
DOI
10.3390/cancers11091221
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Connexins and Integrins in Exosomes
- (2019) Motomu Shimaoka et al. Cancers
- Transforming Growth Factor-β Signaling in Immunity and Cancer
- (2019) Eduard Batlle et al. IMMUNITY
- The integrin αvβ6 drives pancreatic cancer through diverse mechanisms and represents an effective target for therapy
- (2019) Claire S Reader et al. JOURNAL OF PATHOLOGY
- Immune checkpoint blockade therapy for cancer: An overview of FDA-approved immune checkpoint inhibitors
- (2018) Kristian M. Hargadon et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Exosomal αvβ6 integrin is required for monocyte M2 polarization in prostate cancer
- (2018) Huimin Lu et al. MATRIX BIOLOGY
- TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis
- (2018) Daniele V. F. Tauriello et al. NATURE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Human monocytes and macrophages regulate immune tolerance via integrin αvβ8–mediated TGFβ activation
- (2018) Aoife Kelly et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Inter- and intra-tumoral heterogeneity in cancer-associated fibroblasts of human pancreatic ductal adenocarcinoma
- (2018) Cindy Neuzillet et al. JOURNAL OF PATHOLOGY
- Structural basis of latent TGF-β1 presentation and activation by GARP on human regulatory T cells
- (2018) Stéphanie Liénart et al. SCIENCE
- Integrin signaling potentiates transforming growth factor-beta 1 (TGF-β1) dependent down-regulation of E-Cadherin expression – Important implications for epithelial to mesenchymal transition (EMT) in renal cell carcinoma
- (2017) B. Feldkoren et al. EXPERIMENTAL CELL RESEARCH
- Glycoprotein A repetitions predominant (GARP) positively regulates transforming growth factor (TGF) β3 and is essential for mouse palatogenesis
- (2017) Bill X. Wu et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer
- (2017) Daniel Öhlund et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial
- (2017) Arjun V Balar et al. LANCET
- Role of GARP in the activation of latent TGF-β1
- (2017) Julie Stockis et al. Molecular BioSystems
- Force interacts with macromolecular structure in activation of TGF-β
- (2017) Xianchi Dong et al. NATURE
- Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
- (2017) Joaquim Bellmunt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Blocking immunosuppression by human Tregs in vivo with antibodies targeting integrin αVβ8
- (2017) Julie Stockis et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
- (2017) Sadna Budhu et al. Science Signaling
- Blockade of surface-bound TGF-β on regulatory T cells abrogates suppression of effector T cell function in the tumor microenvironment
- (2017) Sadna Budhu et al. Science Signaling
- The Where, the When, and the How of Immune Monitoring for Cancer Immunotherapies in the Era of Checkpoint Inhibition
- (2016) P. S. Hegde et al. CLINICAL CANCER RESEARCH
- Immune-related adverse events with immune checkpoint blockade: a comprehensive review
- (2016) J.M. Michot et al. EUROPEAN JOURNAL OF CANCER
- Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial
- (2016) Jonathan E Rosenberg et al. LANCET
- Exosome-mediated Transfer of v 3 Integrin from Tumorigenic to Nontumorigenic Cells Promotes a Migratory Phenotype
- (2016) A. Singh et al. MOLECULAR CANCER RESEARCH
- Structural Biology and Evolution of the TGF-β Family
- (2016) Andrew P. Hinck et al. Cold Spring Harbor Perspectives in Biology
- Regulation of the Bioavailability of TGF-β and TGF-β-Related Proteins
- (2016) Ian B. Robertson et al. Cold Spring Harbor Perspectives in Biology
- TGF-β and the TGF-β Family: Context-Dependent Roles in Cell and Tissue Physiology
- (2016) Masato Morikawa et al. Cold Spring Harbor Perspectives in Biology
- Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
- (2016) Michael Weller et al. Oncotarget
- αvβ6 integrin is required for TGFβ1-mediated matrix metalloproteinase2 expression
- (2015) Anindita Dutta et al. BIOCHEMICAL JOURNAL
- Immune related adverse events associated with anti-CTLA-4 antibodies: systematic review and meta-analysis
- (2015) Anne Bertrand et al. BMC Medicine
- The TGF-β Signaling Regulator PMEPA1 Suppresses Prostate Cancer Metastases to Bone
- (2015) Pierrick G.J. Fournier et al. CANCER CELL
- Integrin αvβ8-Mediated TGF-β Activation by Effector Regulatory T Cells Is Essential for Suppression of T-Cell-Mediated Inflammation
- (2015) John J. Worthington et al. IMMUNITY
- The αvβ6Integrin Is Transferred Intercellularly via Exosomes
- (2015) Carmine Fedele et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Suppression of TGFβand Angiogenesis by Type VII Collagen in Cutaneous SCC
- (2015) V. L. Martins et al. JNCI-Journal of the National Cancer Institute
- Stromal gene expression defines poor-prognosis subtypes in colorectal cancer
- (2015) Alexandre Calon et al. NATURE GENETICS
- Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study
- (2015) L. Burt Nabors et al. NEURO-ONCOLOGY
- Targeting the TGFβ pathway for cancer therapy
- (2015) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Monoclonal antibodies against GARP/TGF-β1 complexes inhibit the immunosuppressive activity of human regulatory T cells in vivo
- (2015) Julia Cuende et al. Science Translational Medicine
- Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway
- (2015) Michael Lahn et al. Drug Design Development and Therapy
- Prognostic value of tumor-infiltrating FoxP3+ regulatory T cells in cancers: a systematic review and meta-analysis
- (2015) Bin Shang et al. Scientific Reports
- Phenotypic Diversity and Plasticity in Circulating Neutrophil Subpopulations in Cancer
- (2015) Jitka Y. Sagiv et al. Cell Reports
- Suppression of TGFβand Angiogenesis by Type VII Collagen in Cutaneous SCC
- (2015) V. L. Martins et al. JNCI-Journal of the National Cancer Institute
- Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients withKRASwild-type metastatic colorectal cancer: the randomised phase I/II POSEIDON trial
- (2014) E. Élez et al. ANNALS OF ONCOLOGY
- Depletion of Carcinoma-Associated Fibroblasts and Fibrosis Induces Immunosuppression and Accelerates Pancreas Cancer with Reduced Survival
- (2014) Berna C. Özdemir et al. CANCER CELL
- Stromal Elements Act to Restrain, Rather Than Support, Pancreatic Ductal Adenocarcinoma
- (2014) Andrew D. Rhim et al. CANCER CELL
- Integrin v 6 Promotes an Osteolytic Program in Cancer Cells by Upregulating MMP2
- (2014) A. Dutta et al. CANCER RESEARCH
- Release of Active TGF-β1 from the Latent TGF-β1/GARP Complex on T Regulatory Cells Is Mediated by Integrin β8
- (2014) Justin P. Edwards et al. JOURNAL OF IMMUNOLOGY
- Therapeutic Targeting of Integrin αvβ6 in Breast Cancer
- (2014) Kate M. Moore et al. JNCI-Journal of the National Cancer Institute
- Cilengitide combined with standard treatment for patients with newly diagnosed glioblastoma with methylated MGMT promoter (CENTRIC EORTC 26071-22072 study): a multicentre, randomised, open-label, phase 3 trial
- (2014) Roger Stupp et al. LANCET ONCOLOGY
- Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients
- (2014) Roy S. Herbst et al. NATURE
- Structural determinants of integrin β-subunit specificity for latent TGF-β
- (2014) Xianchi Dong et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- E-Cadherin and EpCAM expression by NSCLC tumour cells associate with normal fibroblast activation through a pathway initiated by integrin αvβ6 and maintained through TGFβ signalling
- (2014) C Eberlein et al. ONCOGENE
- 1 Integrin Inhibition Elicits a Prometastatic Switch Through the TGF -miR-200-ZEB Network in E-Cadherin-Positive Triple-Negative Breast Cancer
- (2014) H. H. Truong et al. Science Signaling
- A high M1/M2 ratio of tumor-associated macrophages is associated with extended survival in ovarian cancer patients
- (2014) Meiying Zhang et al. Journal of Ovarian Research
- Hydrogel Micropillars with Integrin Selective Peptidomimetic Functionalized Nanopatterned Tops: A New Tool for the Measurement of Cell Traction Forces Transmitted through αvβ3- or α5β1-Integrins
- (2013) Sabri Rahmouni et al. ADVANCED MATERIALS
- TGF-β Activation and Function in Immunity
- (2013) Mark A. Travis et al. Annual Review of Immunology
- Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion
- (2013) Hildegonda P.H. Naber et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- LOX-Mediated Collagen Crosslinking Is Responsible for Fibrosis-Enhanced Metastasis
- (2013) T. R. Cox et al. CANCER RESEARCH
- Altered Microenvironment Promotes Progression of Preinvasive Breast Cancer: Myoepithelial Expression of v 6 Integrin in DCIS Identifies High-risk Patients and Predicts Recurrence
- (2013) M. D. Allen et al. CLINICAL CANCER RESEARCH
- Targeting TGF-β signaling in cancer
- (2013) Lior H Katz et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Complete integrin headpiece opening in eight steps
- (2013) Jieqing Zhu et al. JOURNAL OF CELL BIOLOGY
- Targeting of αv integrin identifies a core molecular pathway that regulates fibrosis in several organs
- (2013) Neil C Henderson et al. NATURE MEDICINE
- v Integrins in Angiogenesis and Cancer
- (2013) S. M. Weis et al. Cold Spring Harbor Perspectives in Medicine
- TGFβ signaling plays a critical role in promoting alternative macrophage activation
- (2012) Dapeng Gong et al. BMC IMMUNOLOGY
- TGF-β-miR-34a-CCL22 Signaling-Induced Treg Cell Recruitment Promotes Venous Metastases of HBV-Positive Hepatocellular Carcinoma
- (2012) Pengyuan Yang et al. CANCER CELL
- TGF- and v 6 Integrin Act in a Common Pathway to Suppress Pancreatic Cancer Progression
- (2012) A. F. Hezel et al. CANCER RESEARCH
- Complexities of TGF-β Targeted Cancer Therapy
- (2012) Erin C. Connolly et al. International Journal of Biological Sciences
- GARP regulates the bioavailability and activation of TGFβ
- (2012) Rui Wang et al. MOLECULAR BIOLOGY OF THE CELL
- TGF-β is responsible for NK cell immaturity during ontogeny and increased susceptibility to infection during mouse infancy
- (2012) Jeffrey P Marcoe et al. NATURE IMMUNOLOGY
- A human monoclonal antibody 264RAD targeting αvβ6 integrin reduces tumour growth and metastasis and modulates key biomarkers in vivo
- (2012) C Eberlein et al. ONCOGENE
- Biological Significance of Local TGF-β Activation in Liver Diseases
- (2012) Hiromitsu Hayashi et al. Frontiers in Physiology
- The Single-Molecule Mechanics of the Latent TGF-β1 Complex
- (2011) Lara Buscemi et al. CURRENT BIOLOGY
- Switching TGFβ from a tumor suppressor to a tumor promoter
- (2011) Gareth J Inman CURRENT OPINION IN GENETICS & DEVELOPMENT
- Integrin v 5-Mediated TGF- Activation by Airway Smooth Muscle Cells in Asthma
- (2011) A. L. Tatler et al. JOURNAL OF IMMUNOLOGY
- Intestinal epithelial cell-derived integrin αβ6 plays an important role in the induction of regulatory T cells and inhibits an antigen-specific Th2 response
- (2011) Xiao Chen et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Latent TGF-β structure and activation
- (2011) Minlong Shi et al. NATURE
- Integrin Structure, Activation, and Interactions
- (2011) I. D. Campbell et al. Cold Spring Harbor Perspectives in Biology
- A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma
- (2010) Peter Hersey et al. CANCER
- Integrin–TGF-β crosstalk in fibrosis, cancer and wound healing
- (2010) Coert Margadant et al. EMBO REPORTS
- Expression of αvβ8 integrin on dendritic cells regulates Th17 cell development and experimental autoimmune encephalomyelitis in mice
- (2010) Andrew C. Melton et al. JOURNAL OF CLINICAL INVESTIGATION
- A mosaic mouse model of astrocytoma identifies αvβ8 integrin as a negative regulator of tumor angiogenesis
- (2010) J H Tchaicha et al. ONCOGENE
- TGFβ: a sleeping giant awoken by integrins
- (2010) John J. Worthington et al. TRENDS IN BIOCHEMICAL SCIENCES
- TGF-β and immune cells: an important regulatory axis in the tumor microenvironment and progression
- (2010) Li Yang et al. TRENDS IN IMMUNOLOGY
- Polarization of Tumor-Associated Neutrophil Phenotype by TGF-β: “N1” versus “N2” TAN
- (2009) Zvi G. Fridlender et al. CANCER CELL
- Epithelial-Mesenchymal Transitions in Development and Disease
- (2009) Jean Paul Thiery et al. CELL
- TGF-β Superfamily Signaling in Embryonic Development and Homeostasis
- (2009) Mary Y. Wu et al. DEVELOPMENTAL CELL
- Mice that lack activity of v 6- and v 8-integrins reproduce the abnormalities of Tgfb1- and Tgfb3-null mice
- (2009) P. Aluwihare et al. JOURNAL OF CELL SCIENCE
- VEGF and inhibitors of TGF type-I receptor kinase synergistically promote blood-vessel formation by inducing 5-integrin expression
- (2009) Z. Liu et al. JOURNAL OF CELL SCIENCE
- Localized and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility
- (2009) Silvia Giampieri et al. NATURE CELL BIOLOGY
- GARP (LRRC32) is essential for the surface expression of latent TGF- on platelets and activated FOXP3+ regulatory T cells
- (2009) D. Q. Tran et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Integrins
- (2008) Rita Silva et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Antibody-Mediated Blockade of Integrin v 6 Inhibits Tumor Progression In vivo by a Transforming Growth Factor- Regulated Mechanism
- (2008) L. A. Koopman Van Aarsen et al. CANCER RESEARCH
- v 6 Integrin Promotes the Invasion of Morphoeic Basal Cell Carcinoma through Stromal Modulation
- (2008) D. Marsh et al. CANCER RESEARCH
- TGF-β: A Master of All T Cell Trades
- (2008) Ming O. Li et al. CELL
- TGFβ in Cancer
- (2008) Joan Massagué CELL
- Integrins and the activation of latent transforming growth factor β1 – An intimate relationship
- (2008) P WIPFF et al. EUROPEAN JOURNAL OF CELL BIOLOGY
- The role of proteases in transforming growth factor-β activation
- (2008) G JENKINS INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Integrin α3β1 Potentiates TGFβ-Mediated Induction of MMP-9 in Immortalized Keratinocytes
- (2007) John M. Lamar et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now